Interestingly, the unique two CPT1C mutations described in humans to date have been associated with hereditary spastic paraplegia (HSP) (Hong et al., 2019; Rinaldi et al., 2015). This evidence concerns the gene CPT1C and hereditary spastic paraplegia.